Cancer TreatmentDrugs Kadcyla A Targeted Therapy for HER2-Positive Cancers Tony Gates October 29, 2024 Kadcyla, also known as trastuzumab emtansine, is a powerful antibody-drug conjugate that revolutionizes the treatment of HER2-positive cancers. This innovative therapy combines the precision of